Reducing residual cardiovascular risk: the relevance of raising high-density lipoprotein cholesterol in patients on cholesterol-lowering treatment

Affiliations

• ¹ University of Oslo and Centre for Preventive Medicine, Ullevål University Hospital, Oslo, Norway. [email protected]
• ² Institute for Clinical Chemistry A and Laboratory Medicine, University of Munster, Germany.
• ³ University Hospital Jean Minjoz, Besançon, France
• ⁴ Dyslipidaemia & Atherosclerosis Research Unit, National Institute for Health & Medical Research (INSERM), Unité 551, Hôpital de la Pitié, Paris, France
• ⁵ Department of Cardiology, West-German Heart Center, University Duisburg-Essen, Germany.
• ⁶ Department of Pharmacological Sciences, University of Milan, Italy.